Hemas Holdings

Hemas Holdings PLC is a diversified Sri Lankan corporate group whose principal areas of activity are consumer products, healthcare, and mobility. The company operates as a house of businesses rather than as a single-product brand, with activities spanning goods and services used by households, healthcare providers, and transportation-related customers. Its core market is Sri Lanka, while the group has also expanded operations into Bangladesh. Hemas is publicly quoted on the Colombo Stock Exchange and has more than 4,000 shareholders. The group is a substantial employer, with the referenced Wikipedia material identifying approximately 5,380 employees. Its public-company structure and broad portfolio distinguish it from a narrowly defined consumer label: Hemas functions as a diversified operating group with multiple business interests and affiliated brands. Healthcare is one of the group's central areas of focus, alongside consumer and mobility activities. The healthcare orientation places Hemas within Sri Lanka's broader health-products and healthcare-services ecosystem, while the consumer portfolio connects the group to everyday household and personal-use categories. Mobility gives the company exposure to transportation-related products or services. The available reference material does not provide a complete brand-by-brand catalogue, financial history, or detailed descriptions of each operating subsidiary, so the group-level description is more reliable than assigning specific products to Hemas without further sourcing. A notable governance transition occurred in 2020. On 25 June 2020, Hemas announced that Kasturi Chellaraja Wilson would become group chief executive officer, succeeding Steven Enderby, with the transition taking effect on 1 October 2020. She had also been appointed deputy CEO, effective 1 July 2020, as part of the succession process. The appointment was notable because Wilson became the first woman to serve as group CEO of a publicly quoted conglomerate in Sri Lanka, according to the cited reference material. Hemas also disclosed a portfolio-disposal decision in December 2020. On 15 December, the company announced the sale of Serendib Hotels to LOLC Group for LKR 792 million. The transaction reflected portfolio management within a diversified group and reduced Hemas's direct involvement in the hotel asset. No additional transaction terms or subsequent operating details are included in the supplied source material. Hemas Holdings therefore represents a Sri Lankan listed conglomerate with a focused, rather than wholly broad-based, portfolio. Its identity is built around operating businesses in consumer, healthcare, and mobility, supported by public-market ownership and regional activity beyond Sri Lanka. More detailed information on its founding, historical acquisitions, current subsidiaries, product brands, financial performance, and present leadership would require additional authoritative corporate or exchange disclosures.

Hemas Holdings is a Sri Lankan diversified corporate group operating primarily in consumer, healthcare, and mobility. The supplied reference identifies Hemas Holdings PLC as a publicly listed company on the Colombo Stock Exchange, with more than 4,000 shareholders and approximately 5,380 employees. The available material does not state the group's founding year, founder, or a detailed chronology of its early development, so those elements remain unspecified. Over time, Hemas developed a portfolio model covering several related but distinct areas of the Sri Lankan economy. Consumer activities connect the group with household and personal-use markets. Healthcare activities place it within the country's health-products and healthcare ecosystem. Mobility activities extend the portfolio into transportation-related business. The group has also operated in hospitality, although the available record documents a later decision to dispose of its Serendib Hotels interest. The company has maintained Sri Lanka as its principal operating base while expanding into Bangladesh. This regional step broadened the group's geographic reach beyond its home market, although the supplied source does not describe the scale, dates, or individual businesses involved in the Bangladeshi operations. A significant leadership event occurred in 2020. On 25 June, Hemas announced the appointment of Kasturi Chellaraja Wilson as group CEO as part of a succession plan. She was to replace Steven Enderby from 1 October 2020 and was also appointed deputy CEO from 1 July 2020. The appointment was described as historically significant because Wilson became the first female group CEO of a publicly quoted conglomerate in Sri Lanka. Later in 2020, Hemas pursued a portfolio transaction involving its hotel business. On 15 December, it announced the sale of Serendib Hotels to LOLC Group for LKR 792 million. The sale illustrates the group's ability to adjust the composition of its holdings and concentrate on its stated consumer, healthcare, and mobility priorities. The provided material does not report further details about the transaction's completion, accounting treatment, or effect on the group's financial results. Hemas's documented history consequently combines diversification, regional expansion, public-market ownership, leadership succession, and portfolio reshaping. A full corporate history would require additional sources covering the group's origins, major subsidiaries, acquisitions, divestments, product brands, financial performance, and post-2020 management.

• 2020

  Kasturi Chellaraja Wilson designated as group CEO

  [1]Hemas Holdingsen.wikipedia.org

  Hemas announced that Kasturi Chellaraja Wilson would succeed Steven Enderby as group CEO from 1 October 2020, following a deputy CEO appointment effective 1 July.

• 2020

  Serendib Hotels sale announced

  [1]Hemas Holdingsen.wikipedia.org

  Hemas announced the sale of Serendib Hotels to LOLC Group for LKR 792 million.

A Sri Lankan diversified corporate group focused on consumer, healthcare, and mobility businesses, with a publicly listed structure and limited regional expansion.

• Consumer goods

  Consumer businesses

  Hemas identifies consumer as one of its principal business areas. The supplied sources do not provide a sufficiently detailed list of individual consumer brands or product categories, so this entry is kept at the group-portfolio level rather than attributing specific products without verification.

• Healthcare

  Healthcare businesses

  Healthcare is a core Hemas focus and forms one of the main pillars of the group's operating portfolio. The available reference does not specify the complete set of healthcare products, services, subsidiaries, or markets, but it establishes healthcare as a central area of group activity.

• Mobility

  Mobility businesses

  Mobility is the third principal area identified for Hemas Holdings. It represents the group's involvement in transportation-related business, although the supplied source does not identify particular vehicle, distribution, service, or technology offerings.

• Hospitality

  Serendib Hotels

  Serendib Hotels was a hospitality asset associated with Hemas. Hemas announced its sale to LOLC Group in December 2020 for LKR 792 million, so it should be treated as a divested rather than current flagship offering.

• 2020

  Divestment of Serendib HotelsStrategy

  Background

  Hemas operated as a diversified group with interests beyond its principal consumer, healthcare, and mobility focus. In December 2020, it announced the sale of Serendib Hotels to LOLC Group.

  Action taken

  Hemas agreed to sell Serendib Hotels to LOLC Group for LKR 792 million.

  Aftermath

  The supplied material does not report the transaction's subsequent completion details or its financial effect on Hemas.

  Reported transaction value. LKR 792 million (Announced 15 December 2020)

  Source

1. 1Hemas Holdingsen.wikipedia.org